Classical hematologist @UnityHealthTO (St. Michael's Hospital) with thrombosis focus. Proud girl daddy x 3. PD for @uoftmedicine Adult Heme Program
Toronto, Ontario
Joined January 2011
- Tweets2.5K
- Following1.3K
- Followers1.9K
- Likes5K
Pinned Tweet
Bleeding & clotting = rock and hard place? Check out our new blog series "BLOOD & CLOTS" debuting now @WeAreCanadiEM canadiem.org/introduction-bl…
Eric Tseng retweeted
It is so painful to share the news of @FralickMike sudden and unexpected passing 💔
Mike was an amazing, inspiring and generous person who touched the lives of many.
As we mourn, please share and consider supporting his wife and 2-year-old daughter. gofund.me/236771146
Eric Tseng retweeted
🩺🧠 I will be chairing this Morning Report–style thrombosis cases, discussed live by an expert panel seeing the cases for the first time.
🎯 Perfect for thrombosis nerds
💻 Free & open to all. Register now! 👇
Hosted by @ThrombosisCan
🩸 #Thrombosis #MedEd
New CPD Webinar: Clinical Challenges in Thrombosis II
Live, unscripted cases. Real-time expert discussion.
March 3 | 7:00 PM ET
Register: thrombosiscan.info/ClinicalC…
This is such an inspiring story!
cbc.ca/news/canada/newfoundl…
Congrats to our amazing hematology graduates this year! Such a privilege to work with you all. @uoftmedicine
Our amazing DDD @sholzberg kicking off the inaugural U of T Hematology Community Building Day! Time to connect, connect, connect! @uoftmedicine
Stunning paper - neonatal thrombotic thrombocytopenic syndrome due to maternal anti-PF4 antibodies!
nejm.org/doi/full/10.1056/NE…
Eric Tseng retweeted
Excellent 🇨🇦representation (including some honorary Canadians 🙃) at @ASH_hematology Run 🏃♀️ this morning. Biggest Type Eh! Running group ever!
Eric Tseng retweeted
Twelve projects led by St. Michael's Hospital have been awarded funding from the @CIHR_IRSC Project Grants. Congratulations to our researchers and their teams for receiving this outstanding recognition and support: bit.ly/2XIfr6y
ALT Clockwise from top left: Drs. Andrew Advani, Tony Antoniou, Ahmed Bayoumi, Yvonne Bombard, Claudia Dos Santos, Greg Fairn, David Gomez, David Mazer, Joanna Sale and Andrea Tricco
Eric Tseng retweeted
Great turnout for the Thrombosis Canada 2024 Conference. Thanks to everyone who joined us today. #Thrombosis #WTDay24 #MedEd
Dr Amye Harrigan describing incidence of heavy menstrual bleeding in DOAC trials @ThrombosisCan
Eric Tseng retweeted
Do you struggle with whether to use anticoagulation for tumor thrombus? Hui et al. showed that patients with tumor thrombus have high risks of VTE, bleeding and mortality, and unfortunately the role of anticoagulation remains unclear.
@TzufeiWang @MarcCarrier1
Read more at jthjournal.org/article/S1538…
Eric Tseng retweeted
Amazing work by Dr @Maddie_Stephen!!
Here, @maddie_stephen and @sholzberg report on new findings on recombinant porcine factor VIII (rpFVIII) for acquired hemophilia A.
52% of patients had cross-reacting anti-human FVIII antibodies, reducing efficacy of rpFVIII in controlling bleeding.
rpthjournal.org/article/S247…
Eric Tseng retweeted
Thank you @LisaHicksMD and @MarcCarrier1 for all your support, highlighting the risks of VTE and bleeding in patients with PCNSL. Hopefully this work can lead to improvements in care for this population.
In this #RPTH Review Article, @adamsuleman03 et al report their findings from a SR and meta-analysis on risk of VTE in 1ry CNS lymphoma
✅Pooled VTE rate= 11%
✅Fatal PE= 4%
✅High-quality data is lacking in this population
@MarcCarrier1 @LisaHicksMD
read rpthjournal.org/article/S247…
In clinic today, I saw a long-time patient in my practice who has had recurrent, significant medical illness
She brought me close to tears when she said:
"Whatever is on your mind these days, I want you to know that everything will be okay"
Amazing when our patients heal us
Eric Tseng retweeted
Thinking about registering to attend the @ThrombosisCan conference? Below are some numbers to consider. Register today at bit.ly/3AeeK9b @TzufeiWang @MarcCarrier1 @LanaCastellucci @EddyLang1 @tsengeric
Eric Tseng retweeted
Ontario's iron deficiency guidelines are changing; the baseline of what's considered a normal amount of iron is increasing. Dr. Michelle @sholzberg, hematologist & scientist at St. Michael's Hospital, has been advocating for this change for years.
cbc.ca/news/canada/toronto/i… 1/3
game-changing - a change in ferritin reference interval in Ontario!
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Eric Tseng retweeted
Incredibly excited to announce the official launch of our hematology education website - CBC Made Easy! Designed for all education levels, this website is a free tool to practice diagnosing various CBC abnormalities
cbcmadeeasy.com
Eric Tseng retweeted
A patient with serious thrombotic episodes was found to have a monoclonal gammopathy of an anti–PF4 antibody. Myeloma therapy reduced the paraprotein level and prevented further thrombotic events. Read the full correspondence: nej.md/3SFWdsN
![The study patient’s key clinical events (including pulmonary embolism [PE], deep-vein thrombosis [DVT], and intracerebral hemorrhage [ICH]), administration of intravenous immune globulin (IVIG) and daratumumab–bortezomib–dexamethasone (DVd), platelet counts, and results of serotonin-release assays over a 2-year period; arrows under DVd represent the first day of each treatment cycle.](https://pbs.twimg.com/media/GUeKy84X0AA92Qu.png?name=orig)
ALT The study patient’s key clinical events (including pulmonary embolism [PE], deep-vein thrombosis [DVT], and intracerebral hemorrhage [ICH]), administration of intravenous immune globulin (IVIG) and daratumumab–bortezomib–dexamethasone (DVd), platelet counts, and results of serotonin-release assays over a 2-year period; arrows under DVd represent the first day of each treatment cycle.
ALT The results of enzyme-linked immunosorbent assay (ELISA) for heparin-induced thrombocytopenia (HIT) and levels of M protein (monoclonal or antibody) in relation to DVd treatment.
This is an important cohort study on OCP use after cessation of anticoagulation therapy for VTE
MEGA case-control study also confirms that OC use is safe during anticoagulant therapy for VTE but risk of recurrent events ⬆️ following anticoagulation cessation (provoked or unprovoked).
doi.org/10.1016/j.jtha.2024.…
@isth